SAB Biotherapeutics, Inc.·4

Sep 22, 5:00 PM ET

Kropotova Alexandra 4

4 · SAB Biotherapeutics, Inc. · Filed Sep 22, 2025

Insider Transaction Report

Form 4
Period: 2025-09-19
Kropotova Alexandra
CHIEF MEDICAL OFFICER
Transactions
  • Tax Payment

    Common Stock

    2025-09-191,97745,272 total
Footnotes (3)
  • [F1]Represents shares of the Issuer's common stock ("Common Stock") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units ("RSUs").
  • [F2]Includes 29,340 shares of Common Stock and 15,932 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended.
  • [F3]Each RSU represents a contingent right to receive one share of Common Stock.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4